RESUMO
In this work, we studied the combination of chemometric methods with chromatographic separations as a strategy applied to the analysis of enantiomers when complete enantioseparation is difficult or requires long analysis times and, in addition, the target signals have interference from the matrix. We present the determination of ibuprofen enantiomers in pharmaceutical formulations containing homatropine as interference by chiral HPLC-DAD detection in combination with partial least-squares algorithms. The method has been applied to samples containing enantiomeric ratios from 95:5 to 99.5:0.5 and coelution of interferents. The results were validated using univariate calibration and without homatropine. Relative error of the method was less than 4.0%, for both enantiomers. Limits of detection (LOD) and quantification (LOQ) for (S)-(+)-ibuprofen were 4.96×10-10 and 1.50×10-9mol, respectively. LOD and LOQ for the R-(-)-ibuprofen were LOD=1.60×10-11mol and LOQ=4.85×10-11mol, respectively. Finally, the chemometric method was applied to the determination of enantiomeric purity of commercial pharmaceuticals. The ultimate goal of this research was the development of rapid, reliable, and robust methods for assessing enantiomeric purity by conventional diode array detector assisted by chemometric tools.
Assuntos
Química Farmacêutica/métodos , Cromatografia Líquida de Alta Pressão , Ibuprofeno/análise , Ibuprofeno/química , Preparações Farmacêuticas/análise , Preparações Farmacêuticas/normas , Tropanos/química , Algoritmos , Calibragem , Combinação de Medicamentos , Análise dos Mínimos Quadrados , Limite de Detecção , Preparações Farmacêuticas/química , Reprodutibilidade dos Testes , EstereoisomerismoRESUMO
An analytical methodology based on differential pulse voltammetry (DPV) on a glassy carbon electrode and the partial least-squares (PLS-1) algorithm for the simultaneous determination of levodopa, carbidopa and benserazide in pharmaceutical formulations was developed and validated. Some sources of bi-linearity deviation for electrochemical data are discussed and analyzed. The multivariate model was developed as a ternary calibration model and it was built and validated with an independent set of drug mixtures in presence of excipients, according with manufacturer specifications. The proposed method was applied to both the assay and the uniformity content of two commercial formulations containing mixtures of levodopa-carbidopa (10:1) and levodopa-benserazide (4:1). The results were satisfactory and statistically comparable to those obtained by applying the reference Pharmacopoeia method based on high performance liquid chromatography. In conclusion, the methodology proposed based on DPV data processed with the PLS-1 algorithm was able to quantify simultaneously levodopa, carbidopa and benserazide in its pharmaceuticals formulations using a ternary calibration model for these drugs in presence of excipients. Furthermore, the model appears to be successful even in the presence of slight potential shifts in the processed data, which have been taken into account by the flexible chemometric PLS-1 approach.
Assuntos
Dopaminérgicos/análise , Técnicas Eletroquímicas/métodos , Algoritmos , Benserazida/análise , Calibragem , Carbidopa/análise , Combinação de Medicamentos , Técnicas Eletroquímicas/normas , Eletrodos , Excipientes , Levodopa/análiseRESUMO
A newly developed multivariate method involving net analyte preprocessing (NAP) was tested using central composite calibration designs of progressively decreasing size regarding the multivariate simultaneous spectrophotometric determination of three active components (phenylephrine, diphenhydramine and naphazoline) and one excipient (methylparaben) in nasal solutions. Its performance was evaluated and compared with that of partial least-squares (PLS-1). Minimisation of the calibration predicted error sum of squares (PRESS) as a function of a moving spectral window helped to select appropriate working spectral ranges for both methods. The comparison of NAP and PLS results was carried out using two tests: (1) the elliptical joint confidence region for the slope and intercept of a predicted versus actual concentrations plot for a large validation set of samples and (2) the D-optimality criterion concerning the information content of the calibration data matrix. Extensive simulations and experimental validation showed that, unlike PLS, the NAP method is able to furnish highly satisfactory results when the calibration set is reduced from a full four-component central composite to a fractional central composite, as expected from the modelling requirements of net analyte based methods.
Assuntos
Preparações Farmacêuticas/química , Espectrofotometria/métodos , CalibragemRESUMO
The mucolitic bromhexine [N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexylamine] has been determined in cotrimoxazole-containing tablets by partial least-squares (PLS-1) multivariate of spectrophotometric calibration data in the spectral range 310-350 nm. In the studied commercial tablets, cotrimoxazole is present in large excess (ca. 100:1 in weight) with respect to bromhexine, and a high degree of spectral overlapping exists among bromhexine and cotrimoxazole components. However, the obtained recoveries are reasonably good with the presently discussed technique.
Assuntos
Bromoexina/análise , Análise dos Mínimos Quadrados , Espectrofotometria Atômica/métodos , Comprimidos/análise , Combinação Trimetoprima e Sulfametoxazol/análise , CalibragemRESUMO
The use of multivariate spectrophotometric calibration for the simultaneous determination of several active components and excipients in ophthalmic solutions is presented. The resolution of five-component mixtures of phenylephrine, chloramphenicol, antipyrine, methylparaben and thimerosal has been accomplished by using partial least-squares (PLS-1) and a variant of the so-called hybrid linear analysis (HLA). Notwithstanding the presence of a large number of components and their high degree of spectral overlap, they have been determined simultaneously with high accuracy and precision, with no interference, rapidly and without resorting to extraction procedures using non aqueous solvents. A simple and fast method for wavelength selection in the calibration step is presented, based on the minimisation of the predicted error sum of squares (PRESS) calculated as a function of a moving spectral window.
RESUMO
Tetracycline has been determined in human serum samples by a combination of: (1) synchronous fluorescence spectra of whole sera treated with Mg2+, and (2) the multivariate calibration methods of partial least-squares (PLS-1) and a variant of the recently introduced hybrid linear analysis (HLA), which does not require the knowledge of pure-component spectra. The calibration set was designed with 50 sera spiked with concentrations of tetracycline in the range 0.0-4.0 micrograms mL-1'. Studies concerning validation, precision, accuracy and figures of merit (selectivity, sensitivity and limit of determination) were also carried out. A novel wavelength-selection procedure was applied to minimize the effect of nonmodeled interferents present in serum samples containing bilirubin, triglycerides, and salicylate. Overall, the performance of the newly developed HLA approach seems to be better than that of PLS-1.
Assuntos
Análise dos Mínimos Quadrados , Modelos Lineares , Espectrometria de Fluorescência/métodos , Tetraciclina/sangue , Calibragem , Humanos , Magnésio/sangue , Magnésio/química , Magnésio/metabolismo , Análise Multivariada , Sensibilidade e Especificidade , Tetraciclina/química , Tetraciclina/metabolismoRESUMO
The use of multivariate spectrophotometric calibration is reported for the analysis of two decongestant tablets, where paracetamol is the principal component and diphenhydramine or phenylpropanolamine are the minor components. The resolution of these mixtures has been accomplished without prior separation or derivatisation, by using partial least-squares (PLS-1) regression analysis of electronic absorption spectral data. Although the molar ratios of paracetamol to the minor components were 38:1 and 25:1 respectively, the latter have been determined with high accuracy and precision, and with no interference from tablet excipients. PLS is able to take into account small deviations of paracetamol from linearity in the studied concentration range. The application of classical least-squares (CLS) analysis yields unsatisfactory results, due to the low absorbances of the minor components within the range where all components obey Beer's law.
Assuntos
Acetaminofen/análise , Analgésicos não Narcóticos/análise , Difenidramina/análise , Antagonistas dos Receptores Histamínicos H1/análise , Descongestionantes Nasais/análise , Fenilpropanolamina/análise , Algoritmos , Análise de Variância , Calibragem , Combinação de Medicamentos , Indicadores e Reagentes , Análise dos Mínimos Quadrados , Espectrofotometria Ultravioleta , ComprimidosRESUMO
The use of multivariate spectrophotometric calibration is presented for the simultaneous determination of the active components of tablets used in the treatment of pulmonary tuberculosis. The resolution of ternary mixtures of rifampicin, isoniazid and pyrazinamide has been accomplished by using partial least squares (PLS-1) regression analysis. Although the components show an important degree of spectral overlap, they have been simultaneously determined with high accuracy and precision, rapidly and with no need of nonaqueous solvents for dissolving the samples. No interference has been observed from the tablet excipients. A comparison is presented with the related multivariate method of classical least squares (CLS) analysis, which is shown to yield less reliable results due to the severe spectral overlap among the studied compounds. This is highlighted in the case of isoniazid, due to the small absorbances measured for this component.
Assuntos
Antituberculosos/análise , Isoniazida/análise , Pirazinamida/análise , Rifampina/análise , Antituberculosos/química , Isoniazida/química , Análise Multivariada , Pirazinamida/química , Rifampina/química , Espectrofotometria/métodos , ComprimidosAssuntos
Anti-Inflamatórios não Esteroides/análise , Diclofenaco/análise , Acetaminofen/química , Betametasona/química , Diclofenaco/química , Excipientes/química , Concentração de Íons de Hidrogênio , Pomadas , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Espectrometria de Fluorescência/métodos , ComprimidosRESUMO
The mucolitic bromhexine [N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexylamine] has been determined in cough suppressant syrups by multivariate spectrophotometric calibration, together with partial least-squares (PLS-1) and hybrid linear analysis (HLA). Notwithstanding the spectral overlapping between bromhexine and syrup excipients, as well as the intrinsic variability of the latter in unknown samples, the recoveries are excellent. A novel method of wavelength selection was also applied, based on the concept of net analyte signal regression, as adapted to the HLA methodology. This method allows one to improve the performance of both PLS-1 and HLA in samples containing nonmodeled interferences.